Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan.
Int J Clin Pract. 2022 Feb 14;2022:9443884. doi: 10.1155/2022/9443884. eCollection 2022.
Despite being the first-line treatment for severe or moderate acne, isotretinoin has several serious side effects that necessitate the evaluation of patients' knowledge about isotretinoin side effects and its proper use.
The current study aim was to explore information needs about isotretinoin by evaluating patients' knowledge about the appropriate use of isotretinoin and its associated side effects.
In addition to the sociodemographic variables, a validated online questionnaire was adopted from the literature to evaluate patients' knowledge about isotretinoin use and its potential side effects. Independent -test and one-way analysis of variance (ANOVA) test were implemented to find the correlation between the study variables and the knowledge score.
The most recognized side effect of isotretinoin therapy was dryness (98.1%). The study patients showed good knowledge about isotretinoin use with a mean knowledge score of 8.1 (SD = 0.7). However, more than half of them (61.0%) mistakenly thought that isotretinoin therapy should be taken continuously for more than 6 months without stop, and some of them did not know that isotretinoin is recommended to be taken with fatty meal (24%) and sunblock (24.6%). Female gender (8.2 (SD = 0.8)) and using isotretinoin for more than 6 months (8.3 (SD = 1.2)) were significantly associated with a higher knowledge score of isotretinoin use (=0.01), when compared with male patients (7.8 (SD = 0.7)) and less than 6-month use of isotretinoin (7.7 (SD = 0.7)).
The lack of patients' information about the potential side effects, duration of therapy, and some instructions on isotretinoin use, such as taking the medication with fatty meal and sunblock, shed the light on the necessity to prepare leaflets, educational brochures, and educational posts via social media in order to improve patients' knowledge about isotretinoin therapy and its optimal use.
尽管异维 A 酸是治疗重度或中度痤疮的一线药物,但它有一些严重的副作用,这就需要评估患者对异维 A 酸副作用及其正确使用的了解程度。
本研究旨在通过评估患者对异维 A 酸正确使用及其相关副作用的了解程度,探讨有关异维 A 酸的信息需求。
除了社会人口统计学变量外,还采用了文献中验证过的在线问卷来评估患者对异维 A 酸使用及其潜在副作用的了解程度。采用独立样本 t 检验和单因素方差分析(ANOVA)检验来寻找研究变量与知识得分之间的相关性。
异维 A 酸治疗最被认可的副作用是干燥(98.1%)。研究患者对异维 A 酸使用的知识表现良好,平均知识得分为 8.1(SD=0.7)。然而,超过一半的患者(61.0%)错误地认为异维 A 酸治疗应该连续服用超过 6 个月而不停药,还有一些患者不知道异维 A 酸建议与脂肪餐(24%)和防晒霜(24.6%)一起服用。与男性患者(7.8(SD=0.7))和使用异维 A 酸少于 6 个月的患者(7.7(SD=0.7))相比,女性(8.2(SD=0.8))和使用异维 A 酸超过 6 个月(8.3(SD=1.2))的患者与更高的异维 A 酸使用知识得分显著相关(=0.01)。
患者对潜在副作用、治疗持续时间以及异维 A 酸使用的一些说明(如与脂肪餐和防晒霜一起服用药物)的了解不足,这表明有必要准备传单、教育手册和通过社交媒体发布教育文章,以提高患者对异维 A 酸治疗及其最佳使用的认识。